Latest Releases

According to a new study led by Northwestern University behavioral scientists, mixed-gender teams tend to produce research that is significantly more innovative and impactful on average than same-gender ones.

People with dementia or Alzheimer's disease often lose their ability to communicate verbally with loved ones. But a Northwestern Medicine study shows how that gap can be bridged with a new music intervention. In it, a live ensemble plays music from a patient’s youth that creates an emotional connection between a patient and their caregiver by allowing them to interact with the music together via singing, dancing and playing simple instruments.

Simple astrophysical simulation accidentally leads to X-shaped galaxy for first time.

Northwestern University and Johns Hopkins University have been awarded a multi-million-dollar grant from the National Heart, Lung, and Blood Institute to study a strategy to prevent stroke in patients with atrial fibrillation (AFib), the most common heart rhythm disorder in adults. The trial will incorporate the use of an app on Apple Watch to monitor AFib to attempt to reduce patients’ continuous and lifelong reliance on blood-thinning medication.

The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease at Northwestern University Feinberg School of Medicine has been awarded a $10.4 million grant from the National Institute on Aging to support the center’s ongoing research on Primary Progressive Aphasia.

Northwestern University has received $10.35 million over four years from the Department of Energy (DOE) to lead an Energy Frontier Research Center (EFRC) focused on developing hydrogen-based energy technologies, an increasingly important need in the face of climate change.

Northwestern University scientists conducted a survey of 530 graduate students, postdoctoral fellows, faculty and staff at U.S. academic institutions to examine their motivations and barriers to participation in science outreach.

Despite clinical trials showing that FDA-approved antiviral therapies like Paxlovid reduce risk of death by as much as 89%, very few infected individuals have used the potentially life-saving treatment.

Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowers the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40%; and over 50% if prescribed early in onset of symptoms, according to a new multi-site clinical trial led by the University of Minnesota Medical School and School of Public Health. Northwestern University Feinberg School of Medicine was one site in the trial.

New process beheads PFAS, causing it to fall apart into benign end products.